loadpatents
name:-0.0090250968933105
name:-0.007256031036377
name:-0.0043258666992188
Schickaneder; Christian Patent Filings

Schickaneder; Christian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schickaneder; Christian.The latest application filed is for "vinorelbine monotartrate and its pharmaceutical use".

Company Profile
6.9.13
  • Schickaneder; Christian - Lauf an der Pegnitz DE
  • Schickaneder; Christian - Dresden DE
  • Schickaneder; Christian - Lauf a.d. Pegnitz DE
  • Schickaneder; Christian - Lauf a.d.P. DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy
Grant 10,526,290 - Schickaneder , et al. J
2020-01-07
Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration
Grant 10,442,773 - Schwab , et al. Oc
2019-10-15
Method for the synthesis of rapamycin derivatives
Grant 10,308,665 - Zabudkin , et al.
2019-06-04
Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy
Grant 10,294,208 - Schickaneder , et al.
2019-05-21
Salts of a dihydroquinazoline derivative
Grant 10,287,254 - Maertens , et al.
2019-05-14
Vinorelbine Monotartrate And Its Pharmaceutical Use
App 20190092792 - Zabudkin; Oleksandr ;   et al.
2019-03-28
Method For The Synthesis Of Rapamycin Derivatives
App 20190010168 - Zabudkin; Oleksandr ;   et al.
2019-01-10
Method For The Synthesis Of Pentostatin
App 20180201966 - Zabudkin; Oleksandr ;   et al.
2018-07-19
Salts of a dihydroquinazoline derivative
App 20170362186 - MAERTENS; Welljanne ;   et al.
2017-12-21
Bendamustine Derivatives and Related Compounds, and Medical Use Thereof in Cancer Therapy
App 20170313663 - SCHICKANEDER; Helmut ;   et al.
2017-11-02
Salts of a dihydroquinazoline derivative
App 20170114026 - MAERTENS; Welljanne ;   et al.
2017-04-27
Salts of a dihydroquinazoline derivative
Grant 9,512,085 - Maertens , et al. December 6, 2
2016-12-06
Crystalline forms of zinc trisodium pentetic acid
Grant 9,447,120 - Schickaneder , et al. September 20, 2
2016-09-20
Method For The Purification Of Epothilones Via Crystallization
App 20160185793 - LUBBE; Mathias ;   et al.
2016-06-30
Amorphous Letermovir And Solid Pharmaceutical Formulations Thereof For Oral Administration
App 20160145216 - SCHWAB; Wilfried ;   et al.
2016-05-26
Crystalline Forms Of Zinc Trisodium Pentetic Acid
App 20160130283 - Schickaneder; Christian
2016-05-12
Bendamustine Derivatives And Related Compounds, And Medical Use Thereof In Cancer Therapy
App 20150152066 - Schickaneder; Helmut ;   et al.
2015-06-04
Salts of a dihydroquinazoline derivative
App 20150045371 - Maertens; Welljanne ;   et al.
2015-02-12
Esters of bendamustine and related compounds, and medical use thereof
Grant 8,809,549 - Schickaneder , et al. August 19, 2
2014-08-19
Esters Of Bendamustine And Related Compounds, And Medical Use Thereof
App 20130289032 - SCHICKANEDER; Helmut ;   et al.
2013-10-31
Process for the preparation of bendamustine hydrochloride and related compounds
App 20130184471 - Schickaneder; Helmut ;   et al.
2013-07-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed